HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad A Ghatei Selected Research

Peptide YY

11/2014Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucose.
12/2011Pancreatic polypeptide meal response may predict gastric band-induced weight loss.
3/2011Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.
11/2008Peptide YY: a gut hormone associated with anorexia during infectious diarrhea in children.
1/2008Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake.
4/2007Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin.
11/2006Peptide YY (PYY) is increased in elderly patients with femoral neck fractures: a prospective cohort study.
8/2006The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients.
9/2005Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad A Ghatei Research Topics

Disease

20Obesity
01/2017 - 03/2002
13Body Weight (Weight, Body)
01/2017 - 12/2002
13Weight Loss (Weight Reduction)
11/2014 - 08/2005
5Neoplasms (Cancer)
02/2015 - 06/2004
5Overweight
11/2014 - 08/2005
5Prader-Willi Syndrome (Syndrome, Prader-Willi)
10/2008 - 03/2002
4Infertility (Sterility)
12/2014 - 11/2009
4Insulin Resistance
11/2014 - 04/2004
4Hyperglycemia
11/2014 - 08/2004
4Hyperphagia (Overeating)
04/2014 - 08/2004
4Anorexia
11/2008 - 10/2003
3Type 2 Diabetes Mellitus (MODY)
04/2013 - 12/2010
3AIDS-Related Complex (ARC)
02/2010 - 06/2004
3Nausea
02/2009 - 08/2006
2Pre-Eclampsia (Preeclampsia)
05/2015 - 11/2010
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2014 - 11/2012
2Neoplasm Metastasis (Metastasis)
06/2012 - 11/2006
2Malnutrition (Nutritional Deficiencies)
10/2007 - 07/2005
2Hyperinsulinism (Hyperinsulinemia)
05/2005 - 04/2004
1Dumping Syndrome (Syndrome, Dumping)
06/2014
1Inborn Genetic Diseases (Disease, Hereditary)
04/2014
1Precocious Puberty
01/2014
1Carcinoma (Carcinomatosis)
06/2012
1Heat Stroke (Heatstroke)
03/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2011
1Mood Disorders (Mood Disorder)
01/2011
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
11/2010
1Endocrine Gland Neoplasms (Cancer, Endocrine)
02/2010
1Amenorrhea
11/2009
1Diarrhea
11/2008
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2008
1Hypertrophy
09/2007
1Thinness
04/2007
1Anorexia Nervosa
04/2007
1Femoral Neck Fractures
11/2006
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
11/2006
1Chronic Kidney Failure (Chronic Renal Failure)
07/2005
1Craniopharyngioma (Craniopharyngiomas)
05/2005

Drug/Important Bio-Agent (IBA)

18Hormones (Hormone)IBA
01/2017 - 08/2004
12Glucagon-Like Peptide 1 (GLP 1)IBA
01/2017 - 06/2004
10GhrelinIBA
03/2011 - 04/2004
9KisspeptinsIBA
05/2015 - 11/2006
9Peptide YYIBA
11/2014 - 09/2005
6LeptinIBA
04/2014 - 03/2002
6OxyntomodulinIBA
07/2010 - 12/2002
5Insulin (Novolin)FDA Link
11/2014 - 04/2004
5Peptides (Polypeptides)IBA
12/2011 - 11/2006
4Appetite Depressants (Anorectics)IBA
07/2013 - 06/2004
2CarbohydratesIBA
01/2017 - 07/2013
2Glucagon (Glukagon)FDA Link
11/2014 - 04/2013
2Glucose (Dextrose)FDA LinkGeneric
11/2014 - 04/2013
2Biomarkers (Surrogate Marker)IBA
06/2012 - 12/2011
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
02/2010 - 11/2004
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
05/2005 - 08/2004
1Peptide Hormones (Polypeptide Hormones)IBA
01/2017
1InulinFDA Link
01/2017
1SteroidsIBA
02/2015
1AmidesIBA
11/2014
1Bile Acids and Salts (Bile Acids)IBA
06/2014
1TachykininsIBA
01/2014
1oligofructoseIBA
07/2013
1AndrogensIBA
11/2012
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2012
1Streptozocin (Streptozotocin)FDA Link
08/2012
1Pancreatic HormonesIBA
12/2011
1Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
12/2011
1Phenobarbital (Luminal)FDA Link
03/2011
1Pharmaceutical PreparationsIBA
01/2011
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2011
1RimonabantIBA
01/2011
1EndocannabinoidsIBA
01/2011
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
07/2010
1alpha-MSHIBA
02/2010
1GonadotropinsIBA
11/2009
1xenin 25 (xenin)IBA
06/2009
1NeurotensinIBA
06/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008
1InterleukinsIBA
11/2008
1Octreotide (Sandostatin)FDA LinkGeneric
10/2008
1Tumor Biomarkers (Tumor Markers)IBA
04/2008
1Amphetamine (Amfetamine)FDA LinkGeneric
04/2008
1ChromograninsIBA
04/2008
1Cocaine (Cocaine HCl)IBA
04/2008
1AcidsIBA
11/2006
1Kisspeptin-1 ReceptorsIBA
11/2006
1CholesterolIBA
07/2005
1Serum AlbuminIBA
07/2005
1Neuropeptide YIBA
05/2005
1neuropeptide Y2 receptorIBA
05/2005
1BIIE 0246IBA
05/2005
1peptide YY (3-36)IBA
05/2005

Therapy/Procedure

9Therapeutics
11/2014 - 06/2004
6Gastric Bypass (Roux-en-Y Gastric Bypass)
06/2014 - 11/2007
6Bariatric Surgery
12/2011 - 01/2006
1Subcutaneous Injections
11/2009
1Operative Surgical Procedures
10/2007
1Biliopancreatic Diversion
09/2007
1Glycemic Control
01/2006
1Peritoneal Dialysis
07/2005
1Intraperitoneal Injections
05/2005